Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
WuXi PharmaTech has enjoyed a close and cooperative relationship withPfizer for many years, with collaborations ranging from synthetic chemistry,parallel medicinal chemistry (PMC), and ADME to bioanalytical services.
Advertisement
"This new agreement further strengthens our already productiverelationship with Pfizer, one of our largest customers for many years, and itis the direct result of our research capability and firm commitment to qualityand customer satisfaction," commented Dr. Ge Li, Chairman and Chief ExecutiveOfficer of WuXi PharmaTech.
Under the new collaboration agreement WuXi PharmaTech in partnership withPfizer will establish ADME assays to provide in vitro screening services oncompounds WuXi PharmaTech synthesizes for Pfizer.
"A high quality and flexible Asia R&D partnership network is critical toPfizer's emerging market and Asia strategy. We want to build strongrelationship with leading Contract Research Organizations such as WuXiPharmaTech to tap into the scientific talents and R&D capabilities in Asia,"commented Dr. Steve Yang, Vice President and Head of Asia R&D at Pfizer.
The evaluation of ADME properties is a key step in the drug discovery anddevelopment process. WuXi will evaluate ADME properties for Pfizer compoundswith the goal of providing this key information to assist Pfizer scientists toimprove the pharmacokinetic properties of their compounds.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. The operating subsidiaries of WuXi PharmaTech areknown as WuXi AppTec. For more information, please visit:http://www.wuxiapptec.com .For more information, please contact: Sherry Shao WuXi PharmaTech (Cayman) Inc. Tel: +86-21-5046-4002 Email: [email protected]
SOURCE WuXi PharmaTech
